04/17/2025

Cladribine

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

04/16/2025

Semaglutide

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

02/29/2024

Ebastine; Carebastine

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

11/08/2023

Nebivolol

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

Ramipril; Ramiprilat

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

Loperamide

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

Tacrolimus

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

Progesterone

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

Montelukast

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE

Quetiapine

MORE NEWS

16/04/2025 11:05

Anapharm Bioanalytics Renews Certification for French Research Tax Credit (CIR)

We are proud to announce the renewal of our Crédit d’Impôt Recherche (CIR) certification for the 2025-2029 period. This enables French companies collaborating with us on research and development projects to continue benefiting from tax incentives.

READ MORE
27/02/2025 16:40

Peptides Series: Understanding Therapeutic Peptides

Therapeutic peptides are transforming modern medicine thanks to their unique advantages over traditional drug therapies. Their molecular structure and biological properties allow them to achieve effects like natural molecules in the body, enabling targeted action with fewer risks of off-target effects.

READ MORE
16/01/2025 10:47

The visit of the Mayor of Barcelona, Jaume Collboni, to Anapharm Bioanalytics

Last Friday, January 10th 2025, we had the honor of welcoming the Mayor of Barcelona, Jaume Collboni, to our facilities. His visit was a special opportunity for us to showcase the work we do at Anapharm Bioanalytics and to reaffirm our commitment to innovation in the field of bioanalysis.

READ MORE